# A Study of Rituxan in the Treatment of Polyneuropathies Associated With Serum IgM Autoantibodies

> **NCT00006072** · PHASE2 · UNKNOWN · sponsor: **National Center for Research Resources (NCRR)**

## Conditions studied

- Peripheral Neuropathy

## Interventions

- **DRUG:** Rituxan

## Key facts

- **NCT ID:** NCT00006072
- **Lead sponsor:** National Center for Research Resources (NCRR)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2005-06-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00006072

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00006072, "A Study of Rituxan in the Treatment of Polyneuropathies Associated With Serum IgM Autoantibodies". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00006072. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*